Bashan Dror
PRESIDENT AND CEO
PurchaseAlert
- Shares
- 56,000
- Price
- $1.81
- Value
- $101,360
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•23 filings
PLX
Protalix BioTherapeutics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 1 CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$101,360
1 distinct insiders
12-month sales
$314.16
1 distinct insiders
Highlighted alerts
3
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
1 executive purchases found
Get PLX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
PLX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
39
Raw transactions
Everything returned by the filing
3
Voluntary view
P/S trades after deterministic checks
36
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 8,500
- Price
- $0.00
- Footnotes
- 4
The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant. Does not include options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035. Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock. The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Bar-Shalev Amos
Director
SaleAlert
- Shares
- 168
- Price
- $1.87
- Value
- $314.16
Schwartz Aharon
Director
PurchaseAlert
- Shares
- 129,000
- Price
- $1.60
- Value
- $205,884
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.